Strait of Hormuz Crisis Disrupts Asia’s Medical Device Supply

Conflict in the Middle East has triggered supply chain shocks, threatening Asia’s medical device manufacturing sector.

Asia: The ongoing Strait of Hormuz blockade has created severe disruptions in Asia’s medical device industry, with shortages of naphtha, a critical petrochemical feedstock driving up costs and forcing production cuts.

Naphtha is essential for producing plastics used in syringes, catheters, and disposable medical devices. With Middle Eastern shipments halted, Asian petrochemical producers are struggling to secure supplies. Companies in Singapore, including PCS and Aster Chemicals, have declared force majeure on shipments, reducing crude runs and tightening hospital procurement.

Industry leaders warn that the crisis could escalate into a healthcare emergency if shortages persist. Malaysia has already flagged risks to dialysis treatment, while India’s medical device association has raised alarms about rising input costs and freight challenges.

The blockade, enforced by U.S. military forces after failed peace talks with Iran, has turned the Strait of Hormuz into a flashpoint for global health security. While humanitarian aid shipments are permitted, medical supply chains remain vulnerable.

For Asia’s healthcare systems, the crisis underscores the fragility of global supply chains and the need for diversification. Policymakers are now exploring regional production hubs and alternative feedstock sources to safeguard medical resilience.